Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: glen who wrote (4063)	1/14/1999 5:14:00 PM
From: Anthony@Pacific	Read Replies (2) \| Respond to of 122087

i will look at it ..tomorrow will be reserved for DBCC and amy be one quick one in the AM..

To: glen who wrote (4063)	1/14/1999 5:53:00 PM
From: Jose Matos	Respond to of 122087

Glen, I agree 100% about CYTL. CYTL, ENMD, and every other small Biotech company are a godsend to all those rats with life threatening and debilitating diseases, but as investments ????? People always over-react to news about being able to cure heart problems, HIV, or multiple scleroris in rats. What's up with that? People are not rats!!! (OK not all people). I also hope to be short CYTL around this price (~ $7+). I did hold off though because it hit 11.75 intraday on a CNBC comment and I thought they might get another mention near the close or maybe go on Squawk box tomorrow so I held off. But now it looks like clear sailing back to the $3 level soon. Jose.